Morphic Holding, Inc.

NasdaqGM:MORF Stock Report

Market Cap: US$1.4b

Morphic Holding Future Growth

Future criteria checks 2/6

Morphic Holding's earnings are forecast to decline at 8.7% per annum while its annual revenue is expected to grow at 76.5% per year. EPS is expected to decline by 2.4% per annum. Return on equity is forecast to be -71.2% in 3 years.

Key information

-8.7%

Earnings growth rate

-2.4%

EPS growth rate

Biotechs earnings growth25.1%
Revenue growth rate76.5%
Future return on equity-71.2%
Analyst coverage

Good

Last updated26 Apr 2024

Recent future growth updates

Recent updates

We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely

Jan 20
We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely

Companies Like Morphic Holding (NASDAQ:MORF) Are In A Position To Invest In Growth

Sep 29
Companies Like Morphic Holding (NASDAQ:MORF) Are In A Position To Invest In Growth

We're Interested To See How Morphic Holding (NASDAQ:MORF) Uses Its Cash Hoard To Grow

Jun 07
We're Interested To See How Morphic Holding (NASDAQ:MORF) Uses Its Cash Hoard To Grow

What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates

Feb 15
What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates

We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely

Jan 03
We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely

What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates

Nov 08
What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates

Morphic GAAP EPS of -$0.68 beats by $0.17, revenue of $60.2M

Aug 03

Revenue Downgrade: Here's What Analysts Forecast For Morphic Holding, Inc. (NASDAQ:MORF)

May 06
Revenue Downgrade: Here's What Analysts Forecast For Morphic Holding, Inc. (NASDAQ:MORF)

Analyst Forecasts Just Became More Bearish On Morphic Holding, Inc. (NASDAQ:MORF)

Mar 01
Analyst Forecasts Just Became More Bearish On Morphic Holding, Inc. (NASDAQ:MORF)

Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation

Feb 17
Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation

We're Not Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn

Nov 03
We're Not Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn

Morphic: Pioneering Integrin Medicines

Oct 13

Morphic Holding (NASDAQ:MORF) Is In A Strong Position To Grow Its Business

Aug 05
Morphic Holding (NASDAQ:MORF) Is In A Strong Position To Grow Its Business

Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth

Apr 05
Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth

Independent Director Vikas Goyal Just Bought A Handful Of Shares In Morphic Holding, Inc. (NASDAQ:MORF)

Mar 09
Independent Director Vikas Goyal Just Bought A Handful Of Shares In Morphic Holding, Inc. (NASDAQ:MORF)

Did Business Growth Power Morphic Holding's (NASDAQ:MORF) Share Price Gain of 126%?

Feb 24
Did Business Growth Power Morphic Holding's (NASDAQ:MORF) Share Price Gain of 126%?

How Many Morphic Holding, Inc. (NASDAQ:MORF) Shares Have Insiders Sold, In The Last Year?

Jan 20
How Many Morphic Holding, Inc. (NASDAQ:MORF) Shares Have Insiders Sold, In The Last Year?

Morphic Holding (MORF) Presents At 39th Annual Healthcare Conference - Slideshow

Jan 14

Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth

Dec 16
Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth

Earnings and Revenue Growth Forecasts

NasdaqGM:MORF - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261-250-203-1957
12/31/20251-229-191-1848
12/31/20240-199-173-17610
3/31/2024N/A-161-129-127N/A
12/31/20231-152-114-112N/A
9/30/20237-136-110-109N/A
6/30/20239-130-106-104N/A
3/31/202369-64-105-104N/A
12/31/202271-59-101-101N/A
9/30/202274-56-97-96N/A
6/30/202275-51-97-96N/A
3/31/202219-106-92-91N/A
12/31/202120-96-84-83N/A
9/30/202116-92-78-77N/A
6/30/202139-61-49-49N/A
3/31/202143-50-48-47N/A
12/31/202045-45-47-46N/A
9/30/202039-47-47-46N/A
6/30/202019-61-65-63N/A
3/31/202017-55-63-61N/A
12/31/201917-43-44-42N/A
9/30/201921-296365N/A
6/30/201915-277273N/A
3/31/20199-248182N/A
12/31/20183-247676N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MORF is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MORF is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MORF is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MORF's revenue (76.5% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: MORF's revenue (76.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MORF is forecast to be unprofitable in 3 years.


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.